{"id":"W4404312631","doi":"10.1007/s40265-024-02111-7","title":"The Utilization of the Accelerated Approval Pathway in Oncology: A Case Study of Pembrolizumab","year":2024,"lang":"en","type":"review","venue":"Drugs","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"ca_institutions":"","funders":"Merck","keywords":"Pembrolizumab; Medicine; Oncology; Internal medicine; Pharmacotherapy; Intensive care medicine; Immunotherapy; Cancer","routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005899851,0.0001953409,0.0009002714,0.0001246505,0.0000504191,0.00001090441,0.0001908557,0.000178912,0.00001331888],"category_scores_gemma":[0.00004067831,0.00008619826,0.0002947404,0.0009709594,0.0001165024,0.00001492989,0.0000791221,0.000365851,0.000002056984],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002212818,"about_ca_system_score_gemma":0.001058827,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0005790505,"about_ca_topic_score_gemma":0.0004832341,"domain_scores_codex":[0.9983622,0.0003427916,0.0007294873,0.0002120819,0.0002223459,0.0001311138],"domain_scores_gemma":[0.9989289,0.0001639212,0.0003561213,0.0004614715,0.0000707697,0.00001878296],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0002441008,0.0003817769,0.000006582359,0.004955279,0.0003852666,0.0001993562,0.003339737,1.239446e-7,0.000005235201,0.00001871151,0.0003463639,0.9901175],"study_design_scores_gemma":[0.001957736,0.0005027645,0.00001563855,0.005364083,0.0009636449,0.0008095176,0.006647028,0.00001535406,0.00001684337,0.000005915359,0.9836034,0.00009803849],"study_design_candidate":"design_other","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.01661144,0.9793614,1.848882e-7,0.00005923803,0.0004090812,0.002328577,0.00002352893,0.00001295655,0.001193599],"genre_scores_gemma":[0.04799189,0.9511535,0.00000161418,0.00002496933,0.00005262845,0.0001621543,0.00001499861,0.00003091278,0.0005673482],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9900194,"threshold_uncertainty_score":0.3515063,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1258573313240699,"score_gpt":0.4139733711353599,"score_spread":0.2881160398112901,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}